Mountain Valley MD Holdings

Mountain Valley MD Holdings is a publicly traded Canadian biotech company developing and commercializing platform technologies across human health, animal health, and agriculture. Its core assets include Quicksome, a liposomal sublingual delivery platform for pharmaceutical and nutraceutical products, Quicksol, a solubility technology for poorly soluble macrocyclic lactone drugs such as ivermectin, and Agrarius, a licensed plant signaling technology for crop productivity and resilience. The company appears to be transitioning from an R&D-heavy model into early commercial execution, with revenue-generating nutraceutical products, agricultural field trials and commercialization efforts in Latin America, and animal husbandry/aquaculture applications. Rather than operating a traditional therapeutic drug pipeline with named clinical programs, MVMD is organized around enabling technologies and product commercialization in multiple verticals. The company is listed on the Canadian Securities Exchange and also trades over the counter in the United States.